Nearly every mass-market brand has at least one three-row SUV. Cars.com recently compared seven of them in our 2020 3-Row SUV Challenge, for which I served as one of three judges. The all-new ...

February 8, 2025 • The Puppy Bowl may look like lawless fun. But there are rules to the annual competition, now in its 21st year. Here's what to know as Team Ruff and Team Fluff hit the turf on ...

Chief executive Emma Walmsley said: “GSK delivered another year of excellent performance in 2024, with strong sales and core profit growth driven by accelerating momentum of our specialty ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results. The post The GSK share price jumps 6% on positive FY 2024 results. Is it a ...

Once the world's best-selling drug, Zantac was pulled from the market in 2020 amid fears that one ... of its shares over the coming 18 months. Emma Walmsley, chief executive of GSK, credited ...

Once the world's best-selling drug, Zantac was pulled from the market in 2020 amid fears that one of its ingredients ... a further £2billion of its shares over the coming 18 months. Emma Walmsley, ...

"We are increasing and prioritising R&D investment to promising new long-acting and specialty medicines in Respiratory, Immunology & Inflammation, Oncology and HIV," CEO Emma Walmsley said in a ...

GSK chief executive Emma Walmsley hailed an ‘excellent’ performance (GSK/PA) Meanwhile, vaccine sales slipped by 4% for the year, driven by a sharp drop for its Arexvy lung disease treatment.

GSK chief executive Emma Walmsley hailed an ‘excellent’ performance (GSK/PA) Meanwhile, vaccine sales slipped by 4% for the year, driven by a sharp drop for its Arexvy lung disease treatment.